KRP-AM1977X Phase I Clinical Study-To assess the effect of KRP-AM1977X on QT/QTc interval in healthy Japanese male subjects
Phase of Trial: Phase I
Latest Information Update: 14 Dec 2016
At a glance
- Drugs Lascufloxacin (Primary)
- Indications Community-acquired pneumonia; Otorhinolaryngological infections; Respiratory tract infections
- Focus Adverse reactions
- Sponsors Kyorin Pharmaceutical
- 02 Nov 2016 Status changed from active, no longer recruiting to completed.
- 09 Jun 2016 New trial record
- 12 May 2016 Status changed from not yet recruiting to active, no longer recruiting.